Tsuji, Daiki
Suzuki, Kenichi
Kawasaki, Yohei
Goto, Koichi
Matsui, Reiko
Seki, Nobuhiko
Hashimoto, Hironobu
Hama, Toshihiro
Yamanaka, Takeharu
Yamamoto, Nobuyuki
Itoh, Kunihiko
Article History
Received: 7 March 2018
Accepted: 3 August 2018
First Online: 10 August 2018
Compliance with ethical standards
:
: DT reports grants from Yakult and personal fees from Chugai, Kyowa Hakko Kirin, Sawai, Taiho, and Nippon Kayaku outside the submitted work. KS reports personal fees from Taiho, Eli Lilly, Bristol-Myers Squibb, Astra Zeneca, Ono, and MSD outside the submitted work. KG reports grants and personal fees from Chugai, Taiho, and Ono; grants from Takeda, during the conduct of the study; grants and personal fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly, MSD, Novartis, Pfizer, Kyowa Hakko Kirin, Merck Serono, RIKEN GENESIS, and GlaxoSmithKline; grants from Eisai, Sumitomo Dainippon Pharma, Oxonc, Astellas Pharma, AbbVie Stemcentrx, and Ignyta; personal fees from Nippon Kayaku, ABBOTT, Quintiles, Life Technologies Japan, and SRL, outside the submitted work. RM reports personal fees from Chugai, Taiho, Yakult, Novartis, Boehringer Ingelheim, Meiji Seika Pharma, Janssen, and Sawai outside the submitted work. NS reports grants and personal fees from Boehringer Ingelheim, personal fees from Eli Lilly, Astra Zeneca, Daiichi Sankyo, MSD, Chugai, Taiho, Ono, and Bristol-Myers Squibb outside the submitted work. HH reports personal fees from Taiho, Ono, and Eli LIlly outside the submitted work. TH reports grants from Yakult, and Sawai, personal fees from Meiji Seika Pharma, and Towa outside the submitted work. TY reports grants and personal fees from Taiho, and Takeda, personal fees from Chugai, and Boehringer Ingelheim outside the submitted work. NY reports grants and personal fees from KYORIN, Ono, Taiho, Pfizer, Chugai, MSD, Daiich Sankyo, and Astra Zeneca, personal fees from M3., Otsuka Pharmaceutical, JASMIN, Bristol-Myers Squibb, Eli Lilly, Novartis Pharma, and FUJIFIRM, grant from Maruho, Shionogi, Meiji Seika Pharma, Quintiles, PAREXEL International, and ACMEDICAL outside the submitted work. All remaining authors have declared no conflicts of interest.